326 related articles for article (PubMed ID: 28550758)
1. Platelets and hemophilia: A review of the literature.
Riedl J; Ay C; Pabinger I
Thromb Res; 2017 Jul; 155():131-139. PubMed ID: 28550758
[TBL] [Abstract][Full Text] [Related]
2. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
[TBL] [Abstract][Full Text] [Related]
3. Defining severity of hemophilia: more than factor levels.
Pavlova A; Oldenburg J
Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
[TBL] [Abstract][Full Text] [Related]
4. Platelets as delivery systems for disease treatments.
Shi Q; Montgomery RR
Adv Drug Deliv Rev; 2010 Sep; 62(12):1196-203. PubMed ID: 20619307
[TBL] [Abstract][Full Text] [Related]
5. Platelets as modifiers of clinical phenotype in hemophilia.
Yee DL
ScientificWorldJournal; 2006 Jun; 6():661-8. PubMed ID: 16832569
[TBL] [Abstract][Full Text] [Related]
6. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
Diamond SL
Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
[TBL] [Abstract][Full Text] [Related]
7. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
Duan X; Tang M; Zhang J; Yu H; Xu R
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
[TBL] [Abstract][Full Text] [Related]
8. Platelets significantly modify procoagulant activities in haemophilia A.
Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
[TBL] [Abstract][Full Text] [Related]
9. Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.
Zhang G; Shi Q; Fahs SA; Kuether EL; Walsh CE; Montgomery RR
Blood; 2010 Aug; 116(8):1235-43. PubMed ID: 20445020
[TBL] [Abstract][Full Text] [Related]
10. Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Knudsen T; Kjalke M; Tranholm M; Nichols TC; Jensen AL; Kristensen AT
Am J Vet Res; 2011 Aug; 72(8):1007-14. PubMed ID: 21801056
[TBL] [Abstract][Full Text] [Related]
11. The central role of thrombin in bleeding disorders.
Negrier C; Shima M; Hoffman M
Blood Rev; 2019 Nov; 38():100582. PubMed ID: 31164248
[TBL] [Abstract][Full Text] [Related]
12. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.
Shi Q; Wilcox DA; Fahs SA; Weiler H; Wells CW; Cooley BC; Desai D; Morateck PA; Gorski J; Montgomery RR
J Clin Invest; 2006 Jul; 116(7):1974-82. PubMed ID: 16823491
[TBL] [Abstract][Full Text] [Related]
13. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
[TBL] [Abstract][Full Text] [Related]
14. Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A.
Cai Y; Shi Q
Front Immunol; 2020; 11():964. PubMed ID: 32595633
[TBL] [Abstract][Full Text] [Related]
15. Prolonged bleeding time in children and young adults with hemophilia.
Buchanan GR; Holtkamp CA
Pediatrics; 1980 Dec; 66(6):951-5. PubMed ID: 7454486
[TBL] [Abstract][Full Text] [Related]
16. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
17. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
Santagostino E; Mancuso ME; Tripodi A; Chantarangkul V; Clerici M; Garagiola I; Mannucci PM
J Thromb Haemost; 2010 Apr; 8(4):737-43. PubMed ID: 20102490
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.
Siegemund T; Petros S; Siegemund A; Scholz U; Engelmann L
Thromb Haemost; 2003 Nov; 90(5):781-6. PubMed ID: 14597971
[TBL] [Abstract][Full Text] [Related]
19. Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.
Grünewald M; Siegemund A; Grünewald A; Konegen A; Koksch M; Griesshammer M
Platelets; 2002 Dec; 13(8):451-8. PubMed ID: 12487778
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets.
Ohmori T; Ishiwata A; Kashiwakura Y; Madoiwa S; Mitomo K; Suzuki H; Hasegawa M; Mimuro J; Sakata Y
Mol Ther; 2008 Aug; 16(8):1359-65. PubMed ID: 18523449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
